Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience

被引:0
|
作者
Johansen, Kirsten L. [1 ]
Acharya, Anjali [2 ]
Cizman, Borut [3 ]
Cobitz, Alexander R. [3 ]
Correa-Rotter, Ricardo [4 ]
Dasgupta, Indranil [5 ,6 ]
Kher, Vijay [7 ]
Lopes, Renato D. [8 ]
Matsumoto, Leonardo [9 ]
Meadowcroft, Amy M. [3 ]
Merege Vieira Neto, Osvaldo [10 ]
Okabe, Marilu [9 ]
Rayner, Brian [11 ]
Silva, Arnold [12 ]
Thomas, Hilary [9 ]
Singh, Ajay K. [13 ,14 ]
机构
[1] Univ Minnesota, Hennepin Healthcare, 730 South 8th St, Minneapolis, MN 55415 USA
[2] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10461 USA
[3] GlaxoSmithKline, Collegeville, PA USA
[4] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[5] Heartlands Hosp, Birmingham, W Midlands, England
[6] Univ Warwick, Coventry, W Midlands, England
[7] Medanta Kidney & Urol Inst, Medanta Med, Gurgaon, India
[8] Duke Hlth, Duke Clin Res Inst, Durham, NC USA
[9] PPD Worldwide Headquarters, Wilmington, NC USA
[10] Serv Nefrol Ribeirao Preto, Sao Paulo, Brazil
[11] Groote Schuur Hosp, Cape Town, South Africa
[12] Boise Kidney & Hypertens Inst, Meridian, ID USA
[13] Brigham & Womens Hosp, Boston, MA 02115 USA
[14] Harvard Med Sch, Boston, MA 02115 USA
来源
KIDNEY360 | 2022年 / 3卷 / 04期
关键词
chronic kidney disease; clinical trial; COVID-19; dialysis; pandemics; SARS-CoV-2;
D O I
10.34067/KID.0006212021
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Key Points The coronavirus disease 2019 pandemic has had an unprecedented effect on health and health care and posed challenges to the conduct of clinical trials. Targeted mitigating strategies, on the basis of early and continued data collection from site surveys, limited disruption to the ASCEND trials. Flexibly allowing hemoglobin assessment at local laboratories to inform randomized treatment dosing was key to limiting the discontinuation of treatment.
引用
收藏
页码:728 / 733
页数:6
相关论文
共 50 条
  • [1] Clinical Trials during the SARS-CoV-2 Pandemic
    Warnock, David G.
    [J]. NEPHRON, 2020, 144 (05) : 248 - 250
  • [2] Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic
    Tan, Aaron C.
    Ashley, David M.
    Khasraw, Mustafa
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3100 - 3103
  • [3] Mutational spectrum of SARS-CoV-2 during the global pandemic
    Kijong Yi
    Su Yeon Kim
    Thomas Bleazard
    Taewoo Kim
    Jeonghwan Youk
    Young Seok Ju
    [J]. Experimental & Molecular Medicine, 2021, 53 : 1229 - 1237
  • [4] Mutational spectrum of SARS-CoV-2 during the global pandemic
    Yi, Kijong
    Kim, Su Yeon
    Bleazard, Thomas
    Kim, Taewoo
    Youk, Jeonghwan
    Ju, Young Seok
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2021, 53 (08): : 1229 - 1237
  • [5] The role of emergency medicine residents during the global SARS-Cov-2 pandemic: The Pavia experience
    Secco, Gianmarco
    Cappa, Giovanni
    Barcella, Bruno
    Perlini, Stefano
    [J]. EMERGENCY CARE JOURNAL, 2021, 17 (01)
  • [6] Rheumatology Patient Experience and Trends During the SARS-COV-2 Pandemic
    Edens, Cuoghi
    Ko, Kichul
    Trotter, Kimberly
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [8] Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience
    Trama, Annalisa
    Proto, Claudia
    Whisenant, Jennifer G.
    Torri, Valter
    Cortellini, Alessio
    Michielin, Olivier
    Barlesi, Fabrice
    Dingemans, Anne-Marie C.
    Van Meerbeeck, Jan
    Pancaldi, Vera
    Mazieres, Julien
    Soo, Ross A.
    Leighl, Natasha B.
    Peters, Solange
    Wakelee, Heather
    Horn, Leora
    Hellmann, Matthew
    Wong, Selina K.
    Garassino, Marina Chiara
    Baena, Javier
    [J]. CANCER CELL, 2020, 38 (05) : 602 - 604
  • [9] Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures
    Silke van Koningsbruggen-Rietschel
    Fiona Dunlevy
    Veerle Bulteel
    Kate Hayes
    Anne Verbrugge
    Hettie M. Janssens
    Nadine Dufeu
    Nicholas J. Simmonds
    Lieven J. Dupont
    Damian G. Downey
    [J]. Trials, 22
  • [10] Challenges for psychotropics in the context of the SARS-Cov-2 pandemic
    Javelot, H.
    Llorca, P-M
    Meyer, G.
    Fossati, P.
    Haffen, E.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2020, 46 (03): : S116 - S118